In some cases, ongoing use may be necessary to help you sustain your progress

Join Michelle at our Clinical Evidence Course Auckland | 23 May 2026 | NZD $1,025 +GST #ClinicalEvidence #MedicalEducation #MedicalAffairs #MarketAccess #LifeSciences #HealthTech #MedTech #ProfessionalDevelopment To view or add a comment, sign in Day - 7 Phase I Clinical Trial Definition First-in-human study Also called: Human Pharmacology Phase MTD (Maximum Tolerable Dose) Phase Study Design Can be: Single-centre / Multi-centre Single-national / Multi-national Subjects Conducted on healthy volunteers (stable physiology) Sample Size 20 100 subjects Objectives 1 Primary Endpoint To determine MTD (Maximum Tolerable Dose) Highest dose tolerated without serious adverse events (SAEs) 2 Secondary Endpoint Study: Pharmacokinetics (PK) Pharmacodynamics (PD) MTD (Maximum Tolerable Dose) Definition Maximum dose of drug that is well tolerated without significant side effects Determination Methods SAD (Single Ascending Dose) MAD (Multiple Ascending Dose) Important Conditions Conducted in in-patient setting Subjects monitored 247 for safety Observe for adverse events (AEs) To view or add a comment, sign in Excited to announce our latest publication in Bentham Science - Medicinal Chemistry "Identification of Novel and Selective COX-2 Inhibitors: Comprehensive In-Silico Investigations" Chronic inflammation underlies some of the most debilitating conditions we face today including arthritis, cancer, cardiovascular disease

Whilst clinical trials have not established a direct link between Mounjaro and loss of libido, some patients report changes in sexual function during treatment
And theyre also finding that the use of GLP-1s might also reduce inflammation, and thatllobviously could open up, you know, a variety of different treatments for so many different types of diseases
Reach out today for more information on our available options, or book an appointment online to begin your journey to better health and wellness!